BostonGene Revenue and Competitors
Estimated Revenue & Valuation
- BostonGene's estimated annual revenue is currently $108.3M per year.
- BostonGene's estimated revenue per employee is $217,000
- BostonGene's total funding is $200M.
- BostonGene's current valuation is $1B. (April 2022)
Employee Data
- BostonGene has 499 Employees.
- BostonGene grew their employee count by 52% last year.
BostonGene's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Laboratory Director and VP, Laboratory Operations | Reveal Email/Phone |
2 | VP, Legal | Reveal Email/Phone |
3 | VP, Research Partnerships | Reveal Email/Phone |
4 | VP Sales | Reveal Email/Phone |
5 | SVP Market Access and Strategy | Reveal Email/Phone |
6 | Associate Director | Reveal Email/Phone |
7 | Senior Director, Precision Medicine | Reveal Email/Phone |
8 | Director, Biopharma Business Development | Reveal Email/Phone |
9 | Human Resources Director | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
BostonGene Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $68.5M | 273 | N/A | N/A | N/A |
What Is BostonGene?
BostonGene is an intelligent biomedical software platform that assists physicians in determining accurate immunological and targeted treatments, personalized for every patient. Despite tremendous advances in medical care, cancer remains the plague of our time. Part of the problem is the many cancer types and growing number of cases. But just as challenging for physicians is the overwhelming amount of new information on cancer treatments that is emerging nearly every day. BostonGene has created a unique solution that continuously collects the latest cancer research and clinical information, estimates the immune fitness and cancer characteristics of each patient, and transforms this knowledge into an automated, intelligent medical advisory system. Through our holistic approach to cancer treatment, BostonGene defines the optimal immunotherapy combination that is appropriate for each individual patient.
keywords:Healthcare, Health Care Information Technology, Personal Health
$200M
Total Funding
499
Number of Employees
$108.3M
Revenue (est)
52%
Employee Growth %
$1B
Valuation
N/A
Accelerator
BostonGene News
BostonGene, a Waltham, MA-based personalized medicine company, closed a $150m Series B funding. NEC Corporation (NEC; TSE: 6701) led the...
We look forward to showcasing our research at the AACR Annual Meeting. Our findings underscore the clinical utility of BostonGene's deep...
BostonGene's innovative computational platform performs AI-based molecular and immune profiling to discover correlations between tumor genomics,...
WALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene Corporation (BostonGene), a biomedical software company, today announced its ...
With $50 million in its pocket, biomedical software startup BostonGene is refreshed and ready to take on the world of cancer treatment. The goal ...
Other Companies in Lincoln
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $192.5M | 531 | 6% | N/A |
#2 | $180.6M | 535 | 6% | N/A |
#3 | $84.2M | 543 | -1% | N/A |
#4 | $188.7M | 559 | 13% | N/A |
#5 | $189M | 560 | -2% | N/A |